clinical pipeline – Talk Bio

Actionable Insights Powered by AI

Odyssey Therapeutics Secures $213M Series D to Accelerate Autoimmune Clinical Portfolio

24 hours ago talkbio0Tagged Autoimmune Diseases, clinical pipeline, Immunoregulation, Inhibitor, investors, Odyssey, Precision - temporal, preclinical programs, Protac, RIPK2, Series D financing, Technology

Odyssey Therapeutics; Series D financing; $213 million; autoimmune diseases; clinical pipeline; preclinical programs; precision immunomodulation; RIPK2 inhibitor; PROTAC technology; investors

Novartis CEO Reveals Strategic Pipeline Reduction by 40% Based on Data-Driven Insights

10 months ago talkbio0Tagged clinical pipeline, Data-Driven, Decision, Drug Industry, Novartis, strategic reduction

Novartis, clinical pipeline, data-driven decisions, pharmaceutical industry, strategic reduction